An estimated 25-40% of patients admitted to hospitals are those with wounds. Amongst these 7-10% contract an infection during hospitalization. While advanced wound dressings and improved procedures present better medical outcomes, the management of chronic/advanced wounds continues to be a complex area of treatment.
Surgical wounds, venous leg ulcers, diabetic foot ulcers, burns and accidents for some of the most difficult wounds to treat, with high amounts of exudate and are frequently risk of infections.
While these add significant financial burden to the individual and the community, the human cost of wounds is often immeasurable – pain, distress, embarrassment, anxiety, prolonged hospital stays, chronic morbidity or even death. An advanced pressure ulcer (stage IV) not only causes the patient considerable pain, but can add three months or longer to the hospital stay. Similar impact is cause by other advanced wounds.
However, a large number of these wounds are preventable/treatable through modern wound dressings that include antibiotic and antibacterial use, debridement, irrigation, vacuum-assisted closure, warming, oxygenation, moist wound healing, and adding cells or other materials to secrete or enhance levels of healing factors.
Amongst these methods, the use of silver as an antibacterial agent is well known and accepted over the years. Antimicrobial Silver can be found in various foam dressings from leading manufacturers and start-ups across the globe. A one of its kind product RTD, goes a step beyond – incorporating Silver, Methylene Blue and Gentian Violet –covalently bonded to a foam matrix.
RTD is based on a proprietary highly absorbent foam that can absorb 20x its weight in exudate. This allows for a longer wear time between changes and further reduces healing time as well. This highly versatile foam can be used for multiple wound types – diabetic foot ulcers, venous stasis ulcers arterial/ischemic ulcers, post-surgical wounds and burns among others.
It is highly effective against the most commonly acquired infections. Independent lab studies have shown RTD to provide sustained antimicrobial protection including MRSA.
No known antimicrobial resistance to singlet oxygen
Singlet oxygen (released by the methylene blue) causes damage to cell membranes (lipid), pili (proteins), extracellular DNA, and other biological molecules, all of which play important roles in biofilm formation.
AIM is now available for commercially available for more information & enquiries – email us at firstname.lastname@example.org.Posted by SkyQuest team | 0 comments